According to the most recent Form 13F that the company has filed with the Securities and Exchange Commission, during the third quarter of 2018, Cubist Systematic Strategies LLC reduced its stake in Forbion European Acquisition Corp. (NASDAQ: FRBN). Following the transactions that took place during that period, the company had a total holding of 495,527 shares of its stock in its possession. Cubist Systematic Strategies LLC disclosed in its most recent filing with the SEC that it owned approximately 3.13% of Forbion European Acquisition, with a market value of $5,000,000.
Recent events have resulted in several institutional investors modifying the total amount of FRBN they held in their portfolios.
In the first three months of the year, Glazer Capital LLC put $156,000 into a new investment in Forbion European Acquisition.
This was done to establish the investment. UBS Group AG increased its investment in Forbion European Acquisition by approximately 249,000 dollars’ worth of additional capital during the first quarter.
This was done so that it could increase its stake in the company.
During the first three months of 2018, Prelude Capital Management LLC established a new position in Forbion European Acquisition by investing approximately 508,000 dollars in the company.
During the first three months of 2018, JPMorgan Chase & Co increased its stake in Forbion European Acquisition by investing approximately 654 thousand dollars.
Last but not least, Basso Capital Management L.P.
Invested approximately $1,995,000 into Forbion European Acquisition during the first quarter by purchasing additional stakes. Shares of the company are currently held by hedge funds and other institutional investors, who collectively account for 55.30% of the total.
NASDAQ: FRBN was first available for trading on Friday with an opening price of $10.44. Forbion European Acquisition Corp. hit an all-time low of $9.90 during the prior year, while the company reached an all-time high of $10.90 during the same period.
The moving averages for the company over the previous 50 days are $10.36; over the previous 200 days, they are $10.21.
Due to its limited number of customers, Forbion European Acquisition INC is classified as a small business.
The corporation’s primary goal is to participate in some kind of corporate combination with one or more other businesses or entities, such as a merger, share exchange, asset acquisition, share purchase, reorganization, or another corporate combination of a similar nature.
This could be a merger, share exchange, asset acquisition, purchase, or reorganization.
The primary purpose of this organization is to investigate potential business opportunities within the European life sciences sector.
Do you have an interest in learning more about the various hedge funds that are monitoring FRBN? HoldingsChannel.com is the place to go if you want to stay current on the most recent 13F filings and insider transactions about Forbion European Acquisition Corp. (NASDAQ: FRBN).
Discussion about this post